MTBC Medical Transcription Billing High Shooter Low Floater Explosiv - 500 Beiträge pro Seite
eröffnet am 27.04.17 05:20:24 von
neuester Beitrag 05.05.17 20:17:35 von
neuester Beitrag 05.05.17 20:17:35 von
Beiträge: 9
ID: 1.251.613
ID: 1.251.613
Aufrufe heute: 0
Gesamt: 1.220
Gesamt: 1.220
Aktive User: 0
ISIN: US55378G1022 · WKN: A2PEFQ
8,4500
USD
+1,68 %
+0,1400 USD
Letzter Kurs 02.04.21 NYSE
Werte aus der Branche Gesundheitswesen
Wertpapier | Kurs | Perf. % |
---|---|---|
0,5736 | +25,87 | |
0,6868 | +24,85 | |
373,83 | +18,26 | |
3,1500 | +11,70 | |
1,7200 | +10,97 |
Wertpapier | Kurs | Perf. % |
---|---|---|
1,2750 | -13,85 | |
0,5925 | -15,36 | |
1,7600 | -21,08 | |
2,1300 | -37,38 | |
73,27 | -49,61 |
MTBC $ HITSTOCK
MTBC Pre-releases 60% YoY Revenue Growth and Selected Preliminary Q1 2017 Financial Results, Reaffirms Guidance
Print
Alert
MEDICAL TRANSCRIPTION BILLING, C (NASDAQ:MTBC)
Historical Stock Chart
1 Month : From Mar 2017 to Apr 2017
Click Here for more MEDICAL TRANSCRIPTION BILLING, C Charts.
SOMERSET, NJ-(Marketwired - Apr 17, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary mHealth and cloud-based healthcare IT solutions, today pre-released selected preliminary, unaudited financial information for the three months ended March 31, 2017, and reaffirmed full year 2017 guidance.
MTBC expects its first quarter revenue to be approximately $8.2 million, which represents approximately 60% year-over-year revenue growth. Moreover, MTBC's GAAP net loss and non-GAAP adjusted EBITDA loss significantly improved in the first quarter of 2017 as compared to the fourth quarter of 2016. These financial results include the MediGain acquisition and are preliminary and subject to revision until the Company reports its first quarter results on May 10, 2017.
Mahmud Haq, Chairman and CEO of MTBC, said, "We are pleased to announce 60% revenue growth over the first quarter of 2016 and that we're on track for full year 2017 revenue of more than $30 million and full year 2017 adjusted EBITDA of $2.0 to $2.5 million." He continued, "Our organic sales initiatives are adding to the growth momentum from our 2016 acquisitions and we're also experiencing significant improvements in our margins as a result of the successful integration of our acquisitions."
MTBC guidance is summarized in the following table:
For the Fiscal Year Ending December 31, 201 Forward Looking Guidance
Revenue $30 - $31 million
Adjusted EBITDA $2.0 - $2.5 million
About MTBC Medical Transcription Billing, Corp. (MTBC) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in a variety of practice sizes and settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on TWITTER, LINKEDIN and FACEBOOK.
Use of Non-GAAP Financial Measures In our earnings releases, prepared remarks, conference calls, slide presentations, and webcasts, we may use or discuss non-GAAP financial measures, as defined by SEC Regulation G. The GAAP financial measure most directly comparable to each non-GAAP financial measure used or discussed, and a reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure, are included in this press release after the condensed consolidated financial statements. Our earnings press releases containing such non-GAAP reconciliations can be found in the Investor Relations section of our web site at ir.mtbc.com.
Forward-Looking Statements This press release contains various forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.
These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to: the Company's ability to manage growth; integrate acquisitions; effectively migrate and keep newly acquired customers and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE MTBC
Company and Investor Contact:
Bill Korn
Chief Financial Officer
Medical Transcription Billing, Corp. bkorn@mtbc.com (732) 873-5133
MTBC Pre-releases 60% YoY Revenue Growth and Selected Preliminary Q1 2017 Financial Results, Reaffirms Guidance
Alert
MEDICAL TRANSCRIPTION BILLING, C (NASDAQ:MTBC)
Historical Stock Chart
1 Month : From Mar 2017 to Apr 2017
Click Here for more MEDICAL TRANSCRIPTION BILLING, C Charts.
SOMERSET, NJ-(Marketwired - Apr 17, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary mHealth and cloud-based healthcare IT solutions, today pre-released selected preliminary, unaudited financial information for the three months ended March 31, 2017, and reaffirmed full year 2017 guidance.
MTBC expects its first quarter revenue to be approximately $8.2 million, which represents approximately 60% year-over-year revenue growth. Moreover, MTBC's GAAP net loss and non-GAAP adjusted EBITDA loss significantly improved in the first quarter of 2017 as compared to the fourth quarter of 2016. These financial results include the MediGain acquisition and are preliminary and subject to revision until the Company reports its first quarter results on May 10, 2017.
Mahmud Haq, Chairman and CEO of MTBC, said, "We are pleased to announce 60% revenue growth over the first quarter of 2016 and that we're on track for full year 2017 revenue of more than $30 million and full year 2017 adjusted EBITDA of $2.0 to $2.5 million." He continued, "Our organic sales initiatives are adding to the growth momentum from our 2016 acquisitions and we're also experiencing significant improvements in our margins as a result of the successful integration of our acquisitions."
MTBC guidance is summarized in the following table:
For the Fiscal Year Ending December 31, 201 Forward Looking Guidance
Revenue $30 - $31 million
Adjusted EBITDA $2.0 - $2.5 million
About MTBC Medical Transcription Billing, Corp. (MTBC) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in a variety of practice sizes and settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on TWITTER, LINKEDIN and FACEBOOK.
Use of Non-GAAP Financial Measures In our earnings releases, prepared remarks, conference calls, slide presentations, and webcasts, we may use or discuss non-GAAP financial measures, as defined by SEC Regulation G. The GAAP financial measure most directly comparable to each non-GAAP financial measure used or discussed, and a reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure, are included in this press release after the condensed consolidated financial statements. Our earnings press releases containing such non-GAAP reconciliations can be found in the Investor Relations section of our web site at ir.mtbc.com.
Forward-Looking Statements This press release contains various forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.
These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to: the Company's ability to manage growth; integrate acquisitions; effectively migrate and keep newly acquired customers and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE MTBC
Company and Investor Contact:
Bill Korn
Chief Financial Officer
Medical Transcription Billing, Corp. bkorn@mtbc.com (732) 873-5133
For Your Attention, As Follws, You can See for Example each News Flows
MTBC Pre-releases 60% YoY Revenue Growth and Selected Preliminary Q1 2017 Financial Results, Reaffirms Guidance
MTBC Selects Dr. Jon Bertman, EHR Pioneer and Founder of Amazing Charts, to Lead TalkEHR
MTBC Announces Partnership with Healthcare Compliance Network
GLTA
MTBC Pre-releases 60% YoY Revenue Growth and Selected Preliminary Q1 2017 Financial Results, Reaffirms Guidance
MTBC Selects Dr. Jon Bertman, EHR Pioneer and Founder of Amazing Charts, to Lead TalkEHR
MTBC Announces Partnership with Healthcare Compliance Network
GLTA
Strong Buying and Holding
GLTA Longs
GLTA Longs
Leute, Hier schnell rein, Hochprozentig $$$$$$$$$$$$$$$$$$$$
MTBC $ NEWS MTBC Announces Signing of Two Key Healthcare Groups New clients expected to generate more than $1 million in annual revenues
Print
Alert
MEDICAL TRANSCRIPTION BILLING, C (NASDAQ:MTBC)
Intraday Stock Chart
Today : Thursday 27 April 2017
Click Here for more MEDICAL TRANSCRIPTION BILLING, C Charts.
New clients expected to generate more than $1 million in annual revenues
SOMERSET, NJ-(Marketwired - Apr 27, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of mHealth and cloud-based clinical and practice management solutions, announced the signing of two new clients yesterday who are expected to generate more than $1 million in combined, recurring, annual revenues, starting in third quarter 2017, marking a record day of new business signings for MTBC.
"We're very pleased to welcome these new clients, who are regional leaders in their respective specialties of pain management and orthopedics," said Karl Johnson, MTBC SVP, Sales and Marketing. He continued, "Yesterday was a record day of closings for us and we'll continue expanding our reach into new markets as we enable healthcare providers to optimize revenues, while reducing operating costs."
During fourth quarter 2016, MTBC closed its largest acquisition to-date and simultaneously launched a new organic growth initiative. As part of this initiative, MTBC hired experienced healthcare sales leaders, expanded its universe of cross-marketing partners, and is on track to attend more than 20 industry conferences during 2017.
"We're excited to see MTBC's new growth initiative begin to generate a strong return on our investment," said Stephen Snyder, MTBC President. He continued, "We believe we're positioned to achieve significant year-over-year revenue growth during 2017, while generating positive adjusted EBITDA for full year 2017."
About MTBC MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers throughout the United States. Our integrated Software-as-a-Service (SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on Twitter, LinkedIn and Facebook.
Forward-Looking Statements This press release contains various forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "anticipate", "believe", "continue", "could", "estimate", "expect", "goals", "intend", "likely", "may", "plan", "potential", "predict", "project", "will" or the negative of these terms or other similar terms and phrases.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.
Forward-looking statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from those anticipated by such statements. These factors include, but are not limited to, the company's ability to manage growth; integrate acquisitions; effectively migrate and keep newly acquired customers and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission. Although we believe that the expectations reflected in the forward-looking statements contained in this press release are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE MTBC
Company and Investor Contact:
Bill Korn
Chief Financial Officer
Medical Transcription Billing, Corp.
bkorn@mtbc.com
732-873-5133
Alert
MEDICAL TRANSCRIPTION BILLING, C (NASDAQ:MTBC)
Intraday Stock Chart
Today : Thursday 27 April 2017
Click Here for more MEDICAL TRANSCRIPTION BILLING, C Charts.
New clients expected to generate more than $1 million in annual revenues
SOMERSET, NJ-(Marketwired - Apr 27, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of mHealth and cloud-based clinical and practice management solutions, announced the signing of two new clients yesterday who are expected to generate more than $1 million in combined, recurring, annual revenues, starting in third quarter 2017, marking a record day of new business signings for MTBC.
"We're very pleased to welcome these new clients, who are regional leaders in their respective specialties of pain management and orthopedics," said Karl Johnson, MTBC SVP, Sales and Marketing. He continued, "Yesterday was a record day of closings for us and we'll continue expanding our reach into new markets as we enable healthcare providers to optimize revenues, while reducing operating costs."
During fourth quarter 2016, MTBC closed its largest acquisition to-date and simultaneously launched a new organic growth initiative. As part of this initiative, MTBC hired experienced healthcare sales leaders, expanded its universe of cross-marketing partners, and is on track to attend more than 20 industry conferences during 2017.
"We're excited to see MTBC's new growth initiative begin to generate a strong return on our investment," said Stephen Snyder, MTBC President. He continued, "We believe we're positioned to achieve significant year-over-year revenue growth during 2017, while generating positive adjusted EBITDA for full year 2017."
About MTBC MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers throughout the United States. Our integrated Software-as-a-Service (SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on Twitter, LinkedIn and Facebook.
Forward-Looking Statements This press release contains various forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "anticipate", "believe", "continue", "could", "estimate", "expect", "goals", "intend", "likely", "may", "plan", "potential", "predict", "project", "will" or the negative of these terms or other similar terms and phrases.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.
Forward-looking statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from those anticipated by such statements. These factors include, but are not limited to, the company's ability to manage growth; integrate acquisitions; effectively migrate and keep newly acquired customers and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the Securities and Exchange Commission. Although we believe that the expectations reflected in the forward-looking statements contained in this press release are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE MTBC
Company and Investor Contact:
Bill Korn
Chief Financial Officer
Medical Transcription Billing, Corp.
bkorn@mtbc.com
732-873-5133
Hätte ja Lust ein zu steigen aber der Sbroker bietet leider nicht den Handelsplatz an daher leider für mich ein Fail.
MTCB $ News Out
MTBC $ Conferenz Call am 10.05.17 / Uhr: 8.30 $$$
Antwort auf Beitrag Nr.: 54.870.859 von t-haier am 05.05.17 08:30:57Ja aber wie handelt bzw. kauft man den in Deutschland ?
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
Wertpapier | Perf. % |
---|---|
+0,86 | |
-3,57 | |
+0,77 | |
-0,72 | |
-0,31 | |
+1,78 | |
+5,02 | |
+0,71 | |
+1,22 | |
+4,48 |
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
213 | ||
196 | ||
195 | ||
71 | ||
33 | ||
32 | ||
28 | ||
26 | ||
25 | ||
24 |